Cronos Group (STU:7CI) Other Stockholders Equity: €-0.0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:7CI Cronos Group Inc STU:7CI
85 GF Score
Price €2.42
GF Value €3.11
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Cronos Group Other Stockholders Equity?

Cronos Group STU:7CI +0.50% 85 Other Stockholders Equity is €-0.0 Mil as of Mar. 2026. GuruFocus rates STU:7CI with a GF Score™ of 85/100 and a GF Value™ of €3.11 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Cronos Group's Other Stockholders Equity for the quarter that ended in Mar. 2026 was €-0.0 Mil.

Cronos Group's quarterly Other Stockholders Equity stayed the same from Sep. 2025 (€0.0 Mil) to Dec. 2025 (€0.0 Mil) but then declined from Dec. 2025 (€0.0 Mil) to Mar. 2026 (€-0.0 Mil).

Cronos Group's annual Other Stockholders Equity declined from Dec. 2023 (€0.0 Mil) to Dec. 2024 (€-0.0 Mil) but then increased from Dec. 2024 (€-0.0 Mil) to Dec. 2025 (€0.0 Mil).

Cronos Group Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Cronos Group's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cronos Group Other Stockholders Equity Chart

Cronos Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.00 -0.00 0.00 -0.00 0.00

Cronos Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -0.00
STU:7CI
85GF Score
Cronos Group Inc STU:7CI
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cronos Group Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of €-0.0 Mil mean?
Cronos Group (STU:7CI) has a Other Stockholders Equity of €-0.0 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Cronos Group and its competitors.
Is Cronos Group's Other Stockholders Equity too high?
Cronos Group's current Other Stockholders Equity is €-0.0 Mil. Overall, Cronos Group has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cronos Group's Other Stockholders Equity compare to ZTS and UTHR?
Cronos Group's Other Stockholders Equity of €-0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Drug Manufacturers company?
A good Other Stockholders Equity depends on the Drug Manufacturers industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Cronos Group and its competitors. Cronos Group's current Other Stockholders Equity is €-0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cronos Group stock overvalued right now?
Based on GuruFocus' analysis, Cronos Group (STU:7CI) is currently considered Modestly Undervalued. The stock's GF Value™ is €3.11, compared to a current price of €2.42 — trading 22.3% below its estimated fair value. The current Other Stockholders Equity is €-0.0 Mil. Cronos Group's overall GF Score™ is 85/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Cronos Group (STU:7CI), the current Other Stockholders Equity is €-0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cronos Group (STU:7CI) Overvalued in 2026?

Based on GuruFocus' analysis, Cronos Group stock appears to be undervalued. The current stock price of €2.42 is trading 22.3% below its estimated GF Value™ of €3.11. GuruFocus considers Cronos Group to be Modestly Undervalued.

Key valuation signals for STU:7CI:

  • Other Stockholders Equity: €-0.0 Mil
  • GF Value™: €3.11 vs. price of €2.42 (22.3% below fair value)
  • GF Score™: 85/100 with 1 warning sign

No single metric tells the full story. See the STU:7CI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cronos Group Business Description

Other Exchanges CRON:USACRON:Canada
Address 4491 Concession Rd 12, Stayner, ON, CAN, L0M 1S0
Cronos Group Inc is a cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology, and product development. With a passion for responsibly elevating the consumer experience, the company is building an iconic brand portfolio. Its diverse international brand portfolio includes Spinach, PEACE NATURALS, LIT, and Lord Jones. The company operates in Canada, Israel, and other countries, with the majority of its revenue generated from Canada.
85GF Score

Get the complete analysis for STU:7CI

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.42
Price
€3.11
GF Value